You are here
Press Releases
February 15, 2012
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding proposed cuts in the Medicare Clinical Laboratory Fee Schedule:
“AdvaMedDx is strongly opposed to further cuts in the Medicare Clinical... Read More
November 28, 2011
WASHINGTON, D.C. Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the MODDERN Cures Act introduced by Rep.... Read More
October 11, 2011
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that discover, develop and manufacture medical diagnostic technologies, has... Read More
June 27, 2011
Gray Sheet - AdvaMedDx Steps Into Public Sphere: Director Details Diagnostics Priorities
For more information, please contact: Wanda Moebius @ (202) 434-7240
###
AdvaMedDx member companies produce advanced, in vitro diagnostic tests that facilitate... Read More
February 28, 2011
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that discover, develop and manufacture diagnostic technologies, today announced... Read More
October 20, 2010
AdvaMedDx Seeing Robust Membership Growth
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that discover, develop and provide... Read More